Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

MDxHealth (MDXH) EBITDA: 2021-2025

Historic EBITDA for MDxHealth (MDXH) over the last 5 years, with Sep 2025 value amounting to -$0.16.

  • MDxHealth's EBITDA rose 60.00% to -$0.16 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.63, marking a year-over-year increase of 14.86%. This contributed to the annual value of -$1.16 for FY2024, which is 30.12% up from last year.
  • Latest data reveals that MDxHealth reported EBITDA of -$0.16 as of Q3 2025, which was down 14.29% from -$0.14 recorded in Q2 2025.
  • In the past 5 years, MDxHealth's EBITDA ranged from a high of $588.0 million in Q2 2022 and a low of -$199,001 during Q2 2023.
  • Its 3-year average for EBITDA is -$18,091, with a median of -$0.19 in 2025.
  • Per our database at Business Quant, MDxHealth's EBITDA skyrocketed by 381.97% in 2022 and then plummeted by 362.50% in 2023.
  • Over the past 5 years, MDxHealth's EBITDA (MRQ) stood at $22.7 million in 2021, then plummeted by 100.00% to -$0.76 in 2022, then surged by 151.32% to $0.39 in 2023, then crashed by 135.90% to -$0.14 in 2024, then decreased by 14.29% to -$0.16 in 2025.
  • Its EBITDA stands at -$0.16 for Q3 2025, versus -$0.14 for Q2 2025 and -$0.19 for Q1 2025.